David Birnbaum

MCU-PH AP-HM

Equipe

Oncologie Prédictive

Aug 2022 Blood

Non-canonical EZH2 drives retinoic acid resistance of variant acute promyelocytic leukemias.

Poplineau M, Platet N, Mazuel A, Hérault L, N'guyen L, Koide S, Nakajima-Takagi Y, Kuribayashi W, Carbuccia N, Haboub L, Vernerey J, Oshima M, Birnbaum D, Iwama A, Duprez E

Oct 2021 Oncogene

Menin inhibition suppresses castration-resistant prostate cancer and enhances chemosensitivity.

Cherif C, Nguyen DT, Paris C, Le TK, Sefiane T, Carbuccia N, Finetti P, Chaffanet M, Kaoutari AE, Vernerey J, Fazli L, Gleave M, Manai M, Barthélémy P, Birnbaum D, Bertucci F, Taïeb D, Rocchi P

Jun 2003 Blood

Gene expression profiling of multiple myeloma reveals molecular portraits in relation to the pathogenesis of the disease.

Magrangeas F, Nasser V, Avet-Loiseau H, Loriod B, Decaux O, Granjeaud S, Bertucci F, Birnbaum D, Nguyen C, Harousseau JL, Bataille R, Houlgatte R, Minvielle S

Voir toutes les publications